Other mutations within PyMT E2F1 KO tumors include COL5A2, with collagen V being a component of the interstitial matrix, COL6A1-3, with collagen VI being abundant in the tumor invasive front21–23 and several integrin and cadherin genes. This evidence concerns the gene CDH17 and neoplasm.